Aira Matrix, an AI developer in India, and Pharmaseed, a pre-clinical CRO in Israel, have partnered to offer AI for preclinical toxicologic pathology studies. The deployment of the AI is via Augmentiqs, within the microscope of senior toxicologic pathologist Dr. Abraham Nyska.